Abstract
Background
Mechanisms of type 2 diabetes remission (T2Dr) after Roux-en-Y gastric bypass (RYGB) in obese patients appear to involve gastrointestinal hormones.
Objective
The objective of this study is to explore changes in ghrelin plasma levels and ghrelin gastrointestinal gene expression (GHRL) after RYGB, and their relationships to T2Dr.
Setting
In 20 obese women with T2D, before and 3 months after RYGB, we assessed GHRL expression by microarray and quantitative RT-PCR in gastrointestinal biopsy samples and plasma levels of ghrelin.
Results
After RYGB, GHRL expression increased in the excluded stomach (p < 0.05) with no change in other gastrointestinal sites. There were no significant changes in ghrelin plasma levels and no correlations with T2Dr.
Conclusions
After RYGB, over-expression of GHRL gene occurs only in the excluded stomach with no correlation to T2Dr.
Abbreviations
- GIT:
-
Gastrointestinal tract
- GLP-1:
-
Glucagon-like peptide-1
- GHRL:
-
Ghrelin gene
- HC-FMUSP:
-
Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo
- RYGB:
-
Roux-en-Y gastric bypass
- T2D:
-
Type 2 diabetes
- T2Dr:
-
Type 2 diabetes remission
- BMI:
-
Body mass index
References
Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomized controlled trial. Diabetologia. 2016;59(5):945–53. https://doi.org/10.1007/s00125-016-3903-x.
Sala PC, Torrinhas RS, Giannella-Neto D, et al. Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol Metab Syndr. 2014;6(1):87. https://doi.org/10.1186/1758-5996-6-87.
Cohen RV, Rubino F, Schiavon C, et al. Diabetes remission without weight loss after duodenal bypass surgery. Surg Obes Relat Dis. 2012;8(5):e66–8. https://doi.org/10.1016/j.soard.2011.07.007.
Gagnon J, Baggio LL, Drucker DJ, et al. Ghrelin is a novel regulator of GLP-1 secretion. Diabetes. 2015;64(5):1513–21. https://doi.org/10.2337/db14-1176.
Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97(1):411–63. https://doi.org/10.1152/physrev.00031.2014.
Rhee NA, Wahlgren CD, Pedersen J, et al. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia. 2015;58(10):2254–8. https://doi.org/10.1007/s00125-015-3696-3.
Sala P, Belarmino G, Machado NM, et al. The SURMetaGIT study: design and rationale for a prospective pan-omics examination of the gastrointestinal response to Roux-en-Y gastric bypass surgery. J Int Med Res. 2016;44(6):1359–75. https://doi.org/10.1177/0300060516667862.
Sala P, Torrinhas RS, Fonseca DC, et al. Type 2 diabetes remission after Roux-en-Y gastric bypass: Evidence for increased expression of jejunal genes encoding regenerating pancreatic islet-derived proteins as a potential mechanism. Obes Surg. 2017;27(4):1123–7. https://doi.org/10.1007/s11695-017-2602-0.
Breitling R, Armengaud P, Amtmann A, et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004;573(1-3):83–92. https://doi.org/10.1016/j.febslet.2004.07.055.
John B. Buse, Sonia Caprio, William T. Cefalu, Antonio Ceriello, Stefano Del Prato, Silvio E. Inzucchi, et al. How do we define cure of diabetes? Diabetes Care 2009;32:2133–2135;
Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3(6):597–601. https://doi.org/10.1016/j.soard.2007.08.004.
Holdstock C, Zethelius B, Sundbom M, et al. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes. 2008;32(11):1640–6. https://doi.org/10.1038/ijo.2008.157.
Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring). 2006;14(9):1553–61. https://doi.org/10.1038/oby.2006.179.
Morey JS, Ryan JC, Van Dolah FM. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online. n8:175–93.
Acknowledgements
We thank Daniele Yumi for the statistical discussion of the data and the late Prof Daniel Giannella Neto who had an important role and participated in this study.
Funding
This study was funded by Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp) project (no. 2011/09612–3) and scholarship DD (2013/03246-0) and by the CAPES scholarship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was performed according to the Declaration of Helsinki and the protocol was approved by the local ethics committee (CAPPesq 1011/09) and registered at www.ClinicalTrials.gov (NCT01251016). Written informed consent was obtained from all patients.
Conflicts of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Fonseca, D.C., Sala, P., Singer, J. et al. Upregulation of Ghrelin Gene Expression in the Excluded Stomach of Obese Women with Type 2 Diabetes After Roux-en-Y Gastric Bypass in the SURMetaGIT Study. OBES SURG 28, 877–880 (2018). https://doi.org/10.1007/s11695-017-3098-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-017-3098-3